|
|
|
|
In this webinar, Nu-Tek BioSciences demonstrates how a collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.
|
|
|
|
|
Variability reduction programs improve biomanufacturing by controlling raw‑material complexity, optimizing critical attributes, and boosting productivity through data‑driven partnerships.
|
|
|
|
|
Adding 0.2% soy peptone to chemically defined media increases CHO IgG production by 30–60%. This animal-free supplementation enhances titers while maintaining high process control.
|
|
|
|
|
Yeast extract significantly enhances E. coli protein production by over 50%, boosts desired protein attributes 4X, and provides a secure animal-free nutrient source for improved bioprocess performance.
|
|
|
|
|
|
|
An animal‑free raw material partner delivering precision manufacturing, audit‑ready compliance, and tailored variability control—helping biopharma scale faster with lower risk and confidence.
|
|
|
|
|
|
|
See plant-based peptones used for plasmid production in E. coli, demonstrating strong growth performance, consistent plasmid yields, and reduced contamination risk for biopharmaceutical manufacturing.
|
|
|